Drug Profile
Research programme: MOR 102 antibodies - MorphoSys
Alternative Names: IgG4 antibody - Morphosys; MOR 102 antibodies; MOR 102 antibodies research programme - MorphoSys; MOR102Latest Information Update: 16 Mar 2006
Price :
$50
*
At a glance
- Originator MorphoSys
- Class Anti-inflammatories; Antipsoriatics; Monoclonal antibodies
- Mechanism of Action Intercellular adhesion molecule 1 antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psoriasis